These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6845798)

  • 21. Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin.
    Reckers R; Wendt H
    Clin Ther; 1980; 3(3):190-3. PubMed ID: 7459929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.
    Schalla W; Schorning S
    Skin Pharmacol; 1991; 4(3):191-204. PubMed ID: 1768431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [1.0 percent alcinonide ointment, a new topical corticosteroid preparation: clinico-therapeutic evaluation].
    Ponzio F; Scalese A; Spagnoli U
    Clin Ter; 1980 May; 93(3):295-309. PubMed ID: 7449343
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of synemol cream and other topical corticosteroid creams using the vasoconstrictor bioassay.
    Strand LJ; Flatman CJ; Northway CS; Evans CD
    Cutis; 1977 May; 19(5):689-91. PubMed ID: 862429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norwegian scabies following topical corticosteroid therapy.
    Lipitz R; Tur E; Brenner S; Krakowski A
    Isr J Med Sci; 1981 Dec; 17(12):1165-8. PubMed ID: 7327916
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical corticosteroid allergy in an urban Australian centre.
    Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R
    Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A qualitative estimate of the influence of halcinonide concentration and urea on the reservoir formation in the stratum corneum.
    Clarys P; Gabard B; Barel AO
    Skin Pharmacol Appl Skin Physiol; 1999; 12(1-2):85-9. PubMed ID: 10325587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed hypersensitivity to topical corticosteroids.
    Reitamo S; Lauerma AI; Stubb S; Käyhkö K; Visa K; Förström L
    J Am Acad Dermatol; 1986 Apr; 14(4):582-9. PubMed ID: 3958273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A clinical trial of desired and unwanted effects of topically applied glucocorticosteroids in the human].
    Behrendt H; Korting HC
    Hautarzt; 1990 Jan; 41(1):2-8. PubMed ID: 2179168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible dosage regimens for topical steroids, assessed by vasoconstrictor assays using multiple applications.
    Woodford R; Haigh JM; Barry BW
    Dermatologica; 1983; 166(3):136-40. PubMed ID: 6852325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians.
    Fleischer AB; Feldman SR
    Clin Ther; 1999 Oct; 21(10):1725-31. PubMed ID: 10566568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dermoxine--a new steroid in dermatological practice].
    Schöldgen W
    Z Hautkr; 1978 Aug; 53(15):548-52. PubMed ID: 685360
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the effect on the hypophysis-adrenal system of diflorasone diacetate in comparison to betamethasone 17-valerate in psoriasis patients].
    Albanese A; Califano L; Puglisi A; Silva A
    G Ital Dermatol Venereol; 1982; 117(5):LV-LIX. PubMed ID: 7187414
    [No Abstract]   [Full Text] [Related]  

  • 35. Postural skin colour changes during the corticosteroid blanching assay.
    Henry F; Fumal I; Piérard GE
    Skin Pharmacol Appl Skin Physiol; 1999; 12(4):199-210. PubMed ID: 10420140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of bioavailability by lowering of fat content in topical formulations.
    Wirén K; Frithiof H; Sjöqvist C; Lodén M
    Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid-induced vasoconstriction in canine skin.
    Marks R; Sawyer M; Barlow JW
    Arch Dermatol Res; 1985; 277(4):318-22. PubMed ID: 4004328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
    Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
    Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.